Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-06-049092
Filing Date
2006-07-27
Accepted
2006-07-26 19:04:01
Documents
1
Period of Report
2006-09-22

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY NOT RELATED TO A CONTESTED MATTER OR MERGER/ACQUISITION a06-16613_1pre14a.htm PRE 14A 235146
  Complete submission text file 0001104659-06-049092.txt   236702
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-16614 | Film No.: 06982603
SIC: 2835 In Vitro & In Vivo Diagnostic Substances